Ability Dynamics announces new exclusive distribution relationship with OPC Health

NewsGuard 100/100 Score

Ability Dynamics, LLC an innovative developer of next-generation prosthetic devices announced a new exclusive distribution relationship with Australian based OPC Health for its flagship products the RUSH™ HiPro and the RUSH™LoPro prosthetic feet.

"In all my 30 years working in the prosthetics industry have I never witnessed so much positive feedback from amputees trying out a new prosthetic foot for the first time," said Paul Coleman, Prosthetics and Orthotics Product Manager.

Coleman continued to say "What has surprised us working with the RUSH™ foot is the universal positive feedback from the amputees fitted here in Australia."

J. Blount Swain, President of Ability Dynamics, LLC said "Coleman's comments are exactly the sort of remarks we are receiving daily in the U.S. as we continue to expand globally. Success in Australia is key to our international expansion plans as we push into these rapidly growing markets globally."

Swain continued, "The opportunity to work with a company as established and recognized as OPC Health is essential to our commitment to work only with partners who already understand and exemplify the high standards Ability Dynamics and our products have meant to our extended RUSH™ family of patients and prosthetists in the United States."

Ability Dynamics, LLC. is actively pursuing distributorships in several other countries.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research demonstrates a bat species' resistance to cancer, pinpoints key genes